TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotage AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
1,886,265
|
1,481,299
|
1,201,474 |
Financial expenses |
41,534
|
13,243
|
11,703 |
Earnings before taxes |
306,949
|
329,178
|
262,335 |
EBITDA |
469,034
|
405,797
|
338,402 |
Total assets |
4,995,259
|
2,212,490
|
1,942,643 |
Current assets |
1,465,857
|
975,236
|
754,822 |
Current liabilities |
710,135
|
391,608
|
302,319 |
Equity capital |
3,704,657
|
1,548,459
|
1,337,030 |
- share capital |
113,460
|
87,970
|
89,720 |
Employees (average) |
674
|
517
|
497 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
74.2%
|
70.0%
|
68.8% |
Turnover per employee |
2,799
|
2,865
|
2,417 |
Profit as a percentage of turnover |
16.3%
|
22.2%
|
21.8% |
Return on assets (ROA) |
7.0%
|
15.5%
|
14.1% |
Current ratio |
206.4%
|
249.0%
|
249.7% |
Return on equity (ROE) |
8.3%
|
21.3%
|
19.6% |
Change turnover |
299,857
|
315,935
|
136,260 |
Change turnover % |
19%
|
27%
|
13% |
Chg. No. of employees |
157
|
20
|
34 |
Chg. No. of employees % |
30%
|
4%
|
7% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.